[HTML][HTML] Inositol pyrophosphates mediate the effects of aging on bone marrow mesenchymal stem cells by inhibiting Akt signaling
Z Zhang, C Zhao, B Liu, D Liang, X Qin, X Li… - Stem cell research & …, 2014 - Springer
Z Zhang, C Zhao, B Liu, D Liang, X Qin, X Li, R Zhang, C Li, H Wang, D Sun, F Cao
Stem cell research & therapy, 2014•SpringerIntroduction Bone marrow-derived mesenchymal stem cells (BM-MSCs) have been
proposed as an ideal autologous stem cell source for cell-based therapy for myocardial
infarction (MI). However, decreased viability and impaired function of aged MSCs hampered
the therapeutic efficacy of engrafted MSCs, and the underlying mechanisms remain
unclarified. Here, we investigated the role of inositol phosphates 6 kinase (IP6Ks) inhibition
on the therapeutic efficacy of BM-MSCs and its underlying mechanism. Methods BM-MSCs …
proposed as an ideal autologous stem cell source for cell-based therapy for myocardial
infarction (MI). However, decreased viability and impaired function of aged MSCs hampered
the therapeutic efficacy of engrafted MSCs, and the underlying mechanisms remain
unclarified. Here, we investigated the role of inositol phosphates 6 kinase (IP6Ks) inhibition
on the therapeutic efficacy of BM-MSCs and its underlying mechanism. Methods BM-MSCs …
Introduction
Bone marrow-derived mesenchymal stem cells (BM-MSCs) have been proposed as an ideal autologous stem cell source for cell-based therapy for myocardial infarction (MI). However, decreased viability and impaired function of aged MSCs hampered the therapeutic efficacy of engrafted MSCs, and the underlying mechanisms remain unclarified. Here, we investigated the role of inositol phosphates 6 kinase (IP6Ks) inhibition on the therapeutic efficacy of BM-MSCs and its underlying mechanism.
Methods
BM-MSCs isolated from young (8-week-old) or aged (18-month-old) donor male C57BL/6 mice, were subjected to hypoxia and serum deprivation (H/SD) injury with or without administration of inositol phosphates 6 kinase (IP6Ks) inhibitor TNP (10 μM). MSC apoptosis induced by H/SD was determined by flow cytometry and TUNEL assays. Protein expressions were evaluated by Western blot assay. Furthermore, the paracrine effects of MSCs were measured by reverse transcriptase–polymerized chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA) analyses.
Results
Aged BM-MSCs exhibited more Inositol pyrophosphate 7 (IP7) production, compared with young BM-MSCs. Meanwhile, the expression of phospho-Akt (Thr308) was significantly decreased in the aged MSCs, resulting in enhanced Bad activation and decreased Bax/Bcl-2 ratio. Moreover, the apoptosis in aged BM-MSCs was increased, compared with young BM-MSCs. Furthermore, TNP administration significantly inhibited IP7 production and increased the phosphorylation of Akt under both normoxic and hypoxic conditions. Meanwhile, IP6Ks inhibition reduced apoptotic index of aged MSCs, associated with decreased expressions of pro-apoptotic proteins Bax and Bad and increased anti-apoptotic protein Bcl-2. The expressions of angiogenic factors, including VEGF, bFGF, IGF-1 and HGF, were decreased in MSCs from aged mice. In addition, TNP administration enhanced the paracrine efficiency of aged BM-MSCs under normoxic and hypoxic conditions.
Conclusions
This study demonstrates for the first time that IP6Ks and IP7 play critical role in the aging related vulnerability to hypoxic injury and impaired paracrine efficiency of BM-MSCs, which is associated with impaired Akt activation.
Springer